Title 21

PART 500

Part 500 - General

PART 500 - GENERAL Authority:21 U.S.C. 321, 331, 342, 343, 348, 351, 352, 353, 360b, 371, 379e. Source:40 FR 13802, Mar. 27, 1975, unless otherwise noted.

21:6.0.1.1.1.1SUBPART A
Subpart A [Reserved]
21:6.0.1.1.1.2SUBPART B
Subpart B - Specific Administrative Rulings and Decisions
21:6.0.1.1.1.2.1.1SECTION 500.23
   500.23 Thermally processed low-acid foods packaged in hermetically sealed containers.
21:6.0.1.1.1.2.1.2SECTION 500.24
   500.24 Emergency permit control.
21:6.0.1.1.1.2.1.3SECTION 500.25
   500.25 Anthelmintic drugs for use in animals.
21:6.0.1.1.1.2.1.4SECTION 500.26
   500.26 Timed-release dosage form drugs.
21:6.0.1.1.1.2.1.5SECTION 500.27
   500.27 Methylene blue-containing drugs for use in animals.
21:6.0.1.1.1.2.1.6SECTION 500.29
   500.29 Gentian violet for use in animal feed.
21:6.0.1.1.1.2.1.7SECTION 500.30
   500.30 Gentian violet for animal drug use.
21:6.0.1.1.1.2.1.8SECTION 500.45
   500.45 Use of polychlorinated biphenyls (PCB's) in the production, handling, and storage of animal feed.
21:6.0.1.1.1.2.1.9SECTION 500.46
   500.46 Hexachlorophene in animal drugs.
21:6.0.1.1.1.2.1.10SECTION 500.50
   500.50 Propylene glycol in or on cat food.
21:6.0.1.1.1.3SUBPART C
Subpart C - Animal Drug Labeling Requirements
21:6.0.1.1.1.3.1.1SECTION 500.51
   500.51 Labeling of animal drugs; misbranding.
21:6.0.1.1.1.3.1.2SECTION 500.52
   500.52 Use of terms such as “tonic”, “tone”, “toner”, or “conditioner” in the labeling of preparations intended for use in or on animals.
21:6.0.1.1.1.3.1.3SECTION 500.55
   500.55 Exemption from certain drug-labeling requirements.
21:6.0.1.1.1.4SUBPART D
Subpart D - Requirements for Specific Animal Drugs
21:6.0.1.1.1.4.1.1SECTION 500.65
   500.65 Epinephrine injection 1:1,000 in 10-milliliter containers for emergency treatment of anaphylactoid shock in cattle, horses, sheep, and swine.
21:6.0.1.1.1.5SUBPART E
Subpart E - Regulation of Carcinogenic Compounds Used in Food-Producing Animals
21:6.0.1.1.1.5.1.1SECTION 500.80
   500.80 Scope of this subpart.
21:6.0.1.1.1.5.1.2SECTION 500.82
   500.82 Definitions.
21:6.0.1.1.1.5.1.3SECTION 500.84
   500.84 Conditions for approval of the sponsored compound.
21:6.0.1.1.1.5.1.4SECTION 500.86
   500.86 Marker residue and target tissue.
21:6.0.1.1.1.5.1.5SECTION 500.88
   500.88 Regulatory method.
21:6.0.1.1.1.5.1.6SECTION 500.90
   500.90 Waiver of requirements.
21:6.0.1.1.1.5.1.7SECTION 500.92
   500.92 Implementation.
21:6.0.1.1.1.6SUBPART F
Subpart F - Methods for Detection of Residues of Carcinogenic Compounds Used in Food-Producing Animals
21:6.0.1.1.1.6.1.1SECTION 500.1410
   500.1410 N-methyl-2-pyrrolidone.